Neurophet
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Neurophet Introduced Use Cases of Its AI-based Brain Imaging Analysis Solutions at the SEACURE Symposium Hosted by Nanyang Technological University in Singapore 2025-12-09 22:00
Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of 'Neurophet AQUA AD' 2025-12-05 22:00
Neurophet Appoints Josh Cohen, Former Executive from a Global Medical AI firm, as Head of Americas Business -- To Accelerate U.S. Market 2025-12-02 22:00
Neurophet and The Florey Strengthen Research Collaboration on 'Neurophet AQUA' to Advance Alzheimer's Disease Diagnosis 2025-11-25 22:00
Neurophet Publishes Clinical Validation Results of 'Neurophet AQUA' in Annals Academy of Medicine Singapore 2025-09-30 21:00
Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer's disease and Dementia Data 2025-09-02 21:00
Neurophet Showcases Full-Cycle Brain Imaging Analysis Solutions for Alzheimer's disease Including 'Neurophet AQUA AD' at AAIC 2025 2025-07-31 21:00
Neurophet Participates in BIO USA 2025: To showcase Brain Imaging Analysis Solutions Including 'Neurophet AQUA AD' 2025-06-13 21:00
Neurophet Participates ASNR 2025: Showcasing Clinical Utility of 'Neurophet AQUA AD' 2025-05-21 21:00
Neurophet Presented Three Research Abstracts on Personalized tDCS at International Brain Stimulation Conference 2025-02-26 22:00
Neurophet to Participate in RSNA 2024: Unveiling Multiple Sclerosis Analysis Technology with Neurophet AQUA 2024-12-05 22:00
Neurophet Secures FDA 510(k) Clearance for Multiple Sclerosis Analysis with 'Neurophet AQUA' 2024-11-25 22:00
Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake Junkil Been in Dual Leadership to Drive Global Growth 2024-11-15 22:00
Neurophet partners with Beijing LADO Technology… Intends to establish Joint Venture in China 2024-10-30 21:00
Neurophet to host Symposium featuring renowned expert in Alzheimer's disease treatment from the U.S. 2024-10-18 21:00
Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis' 2024-10-15 21:00
Neurophet-NTU Singapore, recognized for outstanding joint research 2024-09-09 21:00
Neurophet to launch total solution for AD treatments 'Neurophet AQUA AD' at AAIC 2024 2024-07-25 21:00
Neurophet to present brain stimulation simulation study at OHBM 2024 2024-06-26 21:00
Neurophet to participate BIO USA… exploring global partnership and business 2024-05-31 21:00
1 2